Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects ...

FOX CHASE (WPVI) -- We often connect cancer to one part of the body. Lymphoma, however, can attack almost anywhere. But a ...

A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation period was successfully completed. In a phase 1b/2a trial for patients with ...

Two major contributors to reduced health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) and lymphoma are muscle weakness and fatigue, according to a study ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

In our non-scientific survey, we documented more than a thousand cancer cases and more than 60 cases of leukemia and lymphoma, a related blood cancer. Local 12 traveled to Morgantown, West ...

Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

Evie, 19, started experiencing symptoms of Hodgkin lymphoma in 2024 - but had no idea that's what it was. Hodgkin lympha is an uncommon cancer that develops in the lymphatic system - a network of ...

Roche will present the new data at next week's ASCO congress showing that its bispecific antibody glofitamab can achieve high and durable responses in patients with aggressive lymphoma.